| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,224,535 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vaught Jeffry L |
Exec VP, Chief Scientific Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(189) |
0 |
|
- |
|
| Vaught Jeffry L |
Exec VP, Chief Scientific Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(98,431) |
0 |
|
- |
|
| Savini Carl A |
Exec VP, Chief Admin Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,355) |
0 |
|
- |
|
| Savini Carl A |
Exec VP, Chief Admin Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(84,677) |
0 |
|
- |
|
| Russell Lesley |
Exec VP, Chief Medical Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(367) |
0 |
|
- |
|
| Russell Lesley |
Exec VP, Chief Medical Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(101,228) |
0 |
|
- |
|
| Moley Kevin E |
Director |
– • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000) |
0 |
|
- |
|
| Pappert Gerald J. |
Exec VP & General Counsel |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(75,193) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(200) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(21,661) |
0 |
|
- |
|
| Groehhuysen Wilco |
Exec VP & CFO |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,717) |
0 |
|
- |
|
| Buchi J Kevin |
Chief Executive Officer |
• • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,592) |
0 |
|
- |
|
| Buchi J Kevin |
Chief Executive Officer |
• • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(172,962) |
0 |
|
- |
|
| Aragues Alain |
Exec VP, President Europe |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,275) |
0 |
|
- |
|
| Baldassano Valli F. |
Exec VP, Chief Compliance Off |
• – – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,555) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2011-05-09 |
4 |
S |
$79.71 |
$797,158 |
D/D |
(10,000) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2011-05-09 |
4 |
OE |
$63.98 |
$639,800 |
D/D |
10,000 |
10,000 |
|
- |
|
| Egan William P |
Director |
– • – |
2011-05-06 |
4 |
S |
$79.89 |
$798,900 |
D/D |
(10,000) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2011-05-06 |
4 |
OE |
$63.98 |
$639,800 |
D/D |
10,000 |
10,000 |
|
- |
|
| Buchi J Kevin |
Chief Executive Officer |
• – – |
2011-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
100,462 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$97,264 |
D/D |
(1,504) |
60,931 |
|
- |
|
| Savini Carl A |
EVP, Chief Admin. Off |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$99,721 |
D/D |
(1,542) |
47,177 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical Off |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$89,503 |
D/D |
(1,384) |
63,728 |
|
- |
|
| Grebow Peter E |
Exec. V.P., Cephalon Ventures |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$76,699 |
D/D |
(1,186) |
68,195 |
|
- |
|
| Buchi J Kevin |
Chief Operating Officer |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$104,571 |
D/D |
(1,617) |
109,146 |
|
- |
|
491 Records found
|
|
Page 1 of 20 |
|
|
